December 22 | 2021
First IndiTreat® order received from Labormed, Slovenia
Read more
December 16 | 2021
First hospital joins the IndiTreat® Evaluation Program IGNITE
Read more
December 14 | 2021
2cureX launches IndiTreat® mCRC Start test to guide 1st line treatment
Read more
December 13 | 2021
2cureX reaches the goals for the 2021 rollout plan
Read more
December 9 | 2021
2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey
Read more
November 25 | 2021
2cureX publishes interim report for the third quarter and first nine months of 2021
Read more
November 25 | 2021
2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021
Read more
October 29 | 2021
2cureX – Banbrytande cancerbehandlingstest rullas ut – Mangold Insight Analys
Read more
October 15 | 2021
2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant.
Read more
October 12 | 2021
2cureX provides commercial goals for 2022 at Live Strategy Update on the 12th of October 2021.
Read more
October 5 | 2021
2cureX signs distribution agreement with Labormed in Slovenia
Read more
September 28 | 2021
Specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain
Read more
August 26 | 2021
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021
Read more
August 26 | 2021
2cureX publishes interim report for the second quarter and first half of 2021
Read more
June 22 | 2021
2cureX appoints 2 new VPs for its Commercial Operations
Read more
June 1 | 2021
Management exercise all warrants within the framework of the 2018 incentive program
Read more
May 27 | 2021
2cureX publishes interim report for the first quarter of 2021
Read more
May 27 | 2021
2cureX offentliggör delårsrapport för det första kvartalet 2021
Read more